NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for ATRA


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
2009 SEP 28 ... of patients with newly diagnosed APL are currently treated with all-trans retinoic acid (ATRA) plus anthracycline-based chemotherapy, typically followed by maintenance with...
Subject: CytRx Corporation
Price: $3.00
*
CytRx Reports 2009 Third Quarter Financial Results
2009 NOV 23 ... by binding to its molecular target more selectively than all trans-retinoic acid (ATRA), the current first-line treatment for APL. The FDA has granted Orphan Drug Designation ...
Subject: CytRx Corporation
Price: $3.00
*
CytRx Reports Favorable Progress Update for Its Pivotal Phase 2 Clinical Trial with Tamibarotene as a Third-line Treatment for Acute Promyelocytic Leukemia
2009 SEP 14 ... single agent to adult patients following treatment failure with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). A durable complete response is achieved when no leukemia ...
Subject: CytRx Corporation
Price: $3.00
*
Findings in cancer reported from Louisiana State University
2009 NOV 23 ... of non-melanoma skin cancer. We have determined the effects of all-trans retinoic acid (ATRA), a naturally occurring chemopreventive retinoid, on signal transducer and activator of ...
Subject: Cancer
Price: $3.00
*
Investigators at Department of Agriculture have published new data on immunology
2009 JUL 22 ... were given 100 mu g (low-dose) or 1,000 mu g (high-dose) all-trans retinoic acid (ATRA)/kg body weight in corn oil or corn oil alone per os on days after inoculation (DAI) -1, ...
Subject: Immunology
Price: $3.00
*
New findings from University of Cambridge in the area of osteoarthritis published
2009 AUG 3 ... the United Kingdom, "Vitamin A derivatives, including all-trans-retinoic acid (ATRA), have a well-established role during skeletal development and limb formation and have ...
Subject: Osteoarthritis
Price: $3.00
*
New findings in cell differentiation described from Central South University, Department of Hematology
2009 JUL 20 ... 'Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation,' have been published. "Polycomb repressive complex 2 ...
Subject: Cell Differentiation
Price: $3.00
*
New nephrology study findings have been published by scientists at University of Yamanashi
2009 NOV 9 ... slit diaphragm in the glomerulus. We previously reported that all-trans retinoic acid (ATRA) and 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] induced expression of nephrin in murine ...
Subject: Nephrology
Price: $3.00
*
New skin cancer study results reported from Louisiana State University
2009 JUL 27 ... have attempted to understand the chemopreventive mechanism of all-trans retinoic acid (ATRA), a primary biologically active retinoid, in order to more efficiently utilize retinoids ...
Subject: Skin Cancer
Price: $3.00
*
Recent findings in life sciences described by researchers from Chongqing Medical University
2009 NOV 23 ... heavy chain promoter-driven reporter (MyHC-GLuc), we have demonstrated that either ATRA or 9CRA is able to effectively induce myogenic differentiation, which can be ...
Subject: Life Sciences
Price: $3.00
*
Reports outline myeloma cell biology study results from Soochow University, Jiangsu Institute of Hematology
2009 AUG 31 ... of rosiglitazone (RGZ) alone as well as in combination with all trans-retinoic acid (ATRA) on human myeloma cell lines and try to address its potential mechanism," investigators ...
Subject: Myeloma Cell Biology
Price: $3.00
*
Research by V.G. Oehler and colleagues in leukemia provides new insights
2009 NOV 23 ... only in cell lines that differentiate along this lineage after all-trans retinoic acid (ATRA) exposure. Forced PRAME expression in normal hematopoietic progenitors, however, ...
Subject: Leukemia
Price: $3.00
*
Research from Campinas State University has provided new information about leukemia
2009 AUG 31 ... leukemia, who developed acute respiratory failure from all-trans-retinoic acid (ATRA) syndrome. We applied noninvasive ventilation (NIV, continuous positive airway pressure ...
Subject: Leukemia
Price: $3.00
*
Research from Children's Hospital, Department of Pediatric Hematology has provided new data on leukemia in children
2009 NOV 2 ... major advance in the field of APL treatment has been the use of all-trans-retinoic acid (ATRA). Advances in the treatment of APL have taken this form of AML from a disease with ...
Subject: Leukemia
View Free
Daily News
Article
Research on leukemia reported by scientists at Midwestern University
2009 JUL 27 ... used as a model for studying granulocytic differentiation. All-trans retinoic acid (ATRA) treatment of HL-60 cells promotes granulocytic differentiation and is effective as ...
Subject: Leukemia
Price: $3.00
*
Scientists at Sun Yat-Sen University, College of Stomatology target gene therapy
2009 SEP 28 ... of the present study was to elucidate the mechanism by which all-trans retinoic acid (atRA) induces the cleft palate," investigators in Guangzhou, People's Republic of China ...
Subject: Gene Therapy
Price: $3.00
*
Scientists at University of Utah publish research in myeloma
2009 AUG 31 ... kinase (ERK) signaling pathways. Interestingly, all-trans retinoic acid (ATRA) treatment induced potent cell death and growth inhibition in RAR alpha 2(+) but not RAR ...
Subject: Myeloma
Price: $3.00
*
Studies from H. Boukarabila and co-researchers yield new data on leukemia
2009 JUL 20 ... case of PML/RARA, this repression can be reversed through treatment with all-trans RA (ATRA), leading to leukemic remission," researchers in Marseille, France report. ...
Subject: Leukemia
Price: $3.00
*
Studies from X.R. Chen and co-researchers yield new data on life sciences
2009 NOV 9 ... in the European Journal of Immunology, "We recently found that all trans retinoic acid (ATRA) accelerated B lymphocyte formation. In the current study, we address the question ...
Subject: Life Sciences
Price: $3.00
*
Study findings from University Hospital broaden understanding of acute promyelocytic leukemia therapy
2009 SEP 28 ... subtype of acute leukemias in adults due to the inclusion of all-trans-retinoic acid (ATRA) in the treatment," scientists in Olomouc, Czech Republic report. ...
Subject: Acute Promyelocytic Leukemia Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login